STOCK TITAN

Absci Corp Financials

ABSI
Trailing 12 months to June 30, 2026
Revenue $1.6M -62.3% YoY
Net Income -$121.1M -6.9% YoY
EPS (Diluted) -$0.79 +16.8% YoY
Free Cash Flow -$109.2M -42.3% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Absci Corp (ABSI) reported $1.6M in revenue over the twelve months to Jun 30, 2026, down 62.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ABSI FY2025

Development-stage spending is rising faster than revenue, with financing activity funding the widening operating gap.

The business is not yet converting scale into operating leverage: from FY2024 to FY2025, revenue fell to $2.8M while R&D rose to $81.4M, showing resources are moving toward development despite shrinking commercial scale. Because FY2025 free cash flow of -$94.0M nearly matched operating cash flow of -$92.9M, the cash requirement is mainly operating and development spending rather than heavy physical reinvestment.

Operating efficiency deteriorated: operating margin reached -43.0% in FY2025 as R&D reached $81.4M. That compares with -24.0% in FY2024, indicating the margin decline accompanied higher development intensity rather than a one-time capital-spending surge.

Despite FY2025 operating cash flow of -$92.9M, financing cash flow was $105.9M, so financing activity offset the year's operating shortfall. Liabilities were lower at year-end while the current ratio rose to 6.6x; the reported liquidity comparison stood at 20.2 months of the latest annual operating outflow.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 50 / 100
Financial Health Score 50/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Absci Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
44
Dilution
34
R&D Intensity
88
Revenue Progress
15
Burn Trend
27
Balance Sheet
92
Altman Z-Score Safe
28.24

Absci Corp scores 28.24, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.5B) relative to total liabilities ($26.8M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
2/7

Absci Corp passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

Absci Corp reported a net loss of $115.2M while operations used $92.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Absci Corp reported an operating loss of $120.3M against $209K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2.8M
YoY-38.2%
5Y CAGR-10.1%

Absci Corp generated $2.8M in revenue in fiscal year 2025. This represents a decrease of 38.2% from the prior year.

EBITDA
-$108.6M
YoY-13.7%

Absci Corp's EBITDA was -$108.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 13.7% from the prior year.

Net Income
-$115.2M
YoY-11.7%

Absci Corp reported -$115.2M in net income in fiscal year 2025. This represents a decrease of 11.7% from the prior year.

EPS (Diluted)
-$0.84
YoY+10.6%

Absci Corp earned -$0.84 per diluted share (EPS) in fiscal year 2025. This represents an increase of 10.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$94.0M
YoY-29.2%

Absci Corp recorded an outflow of $94.0M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 29.2% from the prior year.

Cash & Debt
$20.0M
YoY-51.4%
5Y CAGR-22.1%

Absci Corp held $20.0M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
153M
YoY+20.2%

Absci Corp had 153M shares outstanding in fiscal year 2025. This represents an increase of 20.2% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Return on Equity
-60.8%
YoY-3.2pp

Absci Corp's ROE was -60.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 3.2 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$81.4M
YoY+27.5%
5Y CAGR+48.0%

Absci Corp invested $81.4M in research and development in fiscal year 2025. This represents an increase of 27.5% from the prior year.

Capital Expenditures
$1.1M
YoY+174.0%
5Y CAGR-12.7%

Absci Corp invested $1.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 174.0% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

ABSI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ABSI quarterly income statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue$318K+47.9%$215K-66.9%$650K+72.0%$378K-36.3%$593K-49.7%$1.2M+77.3%$665K-60.9%$1.7M
R&D Expenses$22.6M+17.3%$19.3M-24.0%$25.3M+31.7%$19.2M-5.9%$20.5M+25.0%$16.4M-11.0%$18.4M+2.2%$18.0M
SG&A Expenses$9.2M+1.2%$9.1M+5.1%$8.6M+2.1%$8.4M-1.0%$8.5M-10.0%$9.5M+7.3%$8.8M-4.6%$9.3M
Operating Income-$34.2M-10.7%-$30.8M+0.6%-$31.0M-2.9%-$30.2M+3.9%-$31.4M-13.2%-$27.7M+6.9%-$29.8M-3.0%-$28.9M
Interest Expense$2K-88.9%$18K-37.9%$29K-35.6%$45K-19.6%$56K-29.1%$79K-27.5%$109K-16.2%$130K
Income Tax$40K+122.2%$18K+111.1%-$162K-255.8%$104K-20.6%$131K+3375.0%-$4K-119.0%$21K-43.2%$37K
Net Income-$33.2M-12.2%-$29.6M-0.1%-$29.6M-3.0%-$28.7M+6.1%-$30.6M-16.0%-$26.3M+9.1%-$29.0M-5.8%-$27.4M
EPS (Diluted)-$0.21-10.5%-$0.190.0%-$0.19+5.0%-$0.20+16.7%-$0.24-14.3%-$0.21+19.2%-$0.26-8.3%-$0.24

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit.

ABSI Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ABSI quarterly balance sheet
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Total Assets$268.9M+37.5%$195.6M-9.6%$216.3M-11.7%$245.0M+16.7%$209.9M-9.7%$232.4M+8.8%$213.6M-9.2%$235.2M
Current Assets$208.3M+57.8%$132.0M-11.8%$149.6M-14.5%$175.0M+27.4%$137.4M-11.9%$156.0M+16.5%$133.8M-10.9%$150.1M
Cash & Equivalents$107.9M+1150.3%$8.6M-56.9%$20.0M+111.3%$9.5M-75.1%$38.0M-19.1%$47.0M+14.0%$41.2M+7.9%$38.2M
Accounts ReceivableN/AN/AN/A$1.0M+42.9%$700K-49.4%$1.4M$0N/A
Total Liabilities$22.8M-3.5%$23.6M-12.0%$26.8M-22.5%$34.7M-5.1%$36.5M+8.5%$33.7M-2.4%$34.5M+1.7%$33.9M
Current Liabilities$19.6M-2.2%$20.0M-12.0%$22.8M-23.4%$29.7M-5.2%$31.3M+14.8%$27.3M-4.8%$28.7M+7.4%$26.7M
Long-Term DebtN/AN/AN/AN/AN/AN/A$4.0MN/A
Total Equity$246.1M+43.1%$172.0M-9.2%$189.4M-9.9%$210.3M+21.3%$173.4M-12.8%$198.8M+11.0%$179.1M-11.0%$201.3M
Retained Earnings-$687.6M-5.1%-$654.4M-4.7%-$624.8M-5.0%-$595.2M-5.1%-$566.5M-5.7%-$535.9M-5.2%-$509.6M-6.0%-$480.6M

Not reported in any period shown, so not listed: Inventory, Goodwill.

ABSI Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ABSI quarterly cash flow statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Operating Cash Flow-$27.6M-4.8%-$26.3M+9.9%-$29.2M-16.6%-$25.0M-48.3%-$16.9M+22.7%-$21.8M-28.7%-$17.0M+18.2%-$20.7M
Capital Expenditures$1K-96.7%$30K-70.9%-$103K-89.3%$962K+331.4%$223K+792.0%$25K+8.7%$23K-52.1%$48K
Free Cash Flow-$27.6M-4.7%-$26.3M+10.1%-$29.3M-12.7%-$26.0M-52.0%-$17.1M+21.8%-$21.9M-28.7%-$17.0M+18.3%-$20.8M
Investing Cash Flow$24.1M+226.9%$7.4M-62.3%$19.5M+130.7%-$63.7M-804.7%$9.0M+160.1%-$15.0M-179.0%$19.0M+28.6%$14.8M
Financing Cash Flow$102.7M+1259.5%$7.6M+96.7%$3.8M-93.6%$60.3M+6107.7%-$1.0M-102.3%$42.8M+4240.2%$986K+101.2%$490K

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

ABSI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

ABSI quarterly financial ratios
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Operating Margin-10741.5%-14347.0%-4775.5%-7977.2%-5293.9%-2351.9%-4477.3%-1698.7%
Net Margin-10443.4%-13767.0%-4548.0%-7594.2%-5155.0%-2234.6%-4358.4%-1610.7%
Return on Equity-13.5%+3.7pp-17.2%-1.6pp-15.6%-2.0pp-13.7%+4.0pp-17.6%-4.4pp-13.3%+2.9pp-16.2%-2.6pp-13.6%
Return on Assets-12.3%+2.8pp-15.1%-1.5pp-13.7%-1.9pp-11.7%+2.8pp-14.6%-3.2pp-11.3%+2.2pp-13.6%-1.9pp-11.7%
Current Ratio10.63+4.0x6.590.0x6.57+0.7x5.89+1.5x4.39-1.3x5.72+1.0x4.67-1.0x5.63
Debt-to-Equity0.090.0x0.140.0x0.140.0x0.160.0x0.210.0x0.17+0.1x0.02-0.1x0.17
FCF Margin-8668.2%-12249.8%-4505.4%-6876.5%-2883.0%-1854.4%-2554.4%-1221.6%

Not reported in any period shown, so not listed: Gross Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Frequently Asked Questions

What is Absci Corp's annual revenue?

Absci Corp (ABSI) reported $2.8M in total revenue for fiscal year 2025. This represents a -38.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Absci Corp's revenue growing?

Absci Corp (ABSI) revenue declined by 38.2% year-over-year, from $4.5M to $2.8M in fiscal year 2025.

Is Absci Corp profitable?

No, Absci Corp (ABSI) reported a net income of -$115.2M in fiscal year 2025.

Absci Corp (ABSI) reported diluted earnings per share of -$0.84 for fiscal year 2025. This represents a 10.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Absci Corp (ABSI) had EBITDA of -$108.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Absci Corp (ABSI) has a return on equity of -60.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Absci Corp (ABSI) recorded an outflow of $94.0M in free cash flow during fiscal year 2025. This represents a -29.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Absci Corp (ABSI) recorded an outflow of $92.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Absci Corp (ABSI) had $216.3M in total assets as of fiscal year 2025, including both current and long-term assets.

Absci Corp (ABSI) invested $1.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Absci Corp (ABSI) invested $81.4M in research and development during fiscal year 2025.

Absci Corp (ABSI) had 153M shares outstanding as of fiscal year 2025.

Absci Corp (ABSI) had a current ratio of 6.57 as of fiscal year 2025, which is generally considered healthy.

Absci Corp (ABSI) had a debt-to-equity ratio of 0.14 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Absci Corp (ABSI) had a return on assets of -53.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, Absci Corp (ABSI) held $156.1M in cash, cash equivalents and investments, and reported an operating cash outflow of $92.9M over that year. Dividing the one by the other, the reported balance equals about 20 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Absci Corp (ABSI) has an Altman Z-Score of 28.24, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Absci Corp (ABSI) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Absci Corp (ABSI) reported a net loss of $115.2M while operations used $92.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Absci Corp (ABSI) reported an operating loss of $120.3M against $209K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Absci Corp (ABSI) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top